REVIEW ARTICLE
Year : 2023 | Volume
: 13 | Issue : 1 | Page : 10--16
An evidence-based review on host modulatory agents in treatment of peri-implant disease
Mudra Andharia, Jasuma Rai, Monali Shah, Priyanka Sonavane
Department of Periodontology, K M Shah Dental College and Hospital, Sumandeep Vidyapeeth, Deemed to be University, Vadodara, Gujarat, India
Correspondence Address:
Dr. Jasuma Rai
Department of Periodontology, K M Shah Dental College and Hospital, Sumandeep Vidyapeeth, Deemed to be University, Piparia, Waghodia, Vadodara - 391 760, Gujarat
India
Antimicrobials have traditionally been the only chemotherapeutic option for treating periodontitis and peri-implant disorders. With a growing understanding of the host–pathogen interactions in periodontal pathogenesis, novel therapeutic options for periodontitis and peri-implant disorders are developed by focusing on the host response with host-modulating drugs. When employed as host-modifying agents, a variety of sub-antimicrobial dose doxycycline (SDD), bisphosphonates and non-steroidal anti-inflammatory drugs were found to be successful in both experimental animal research and human trials. The current state and future prospects of host modulatory agents used to treat peri-implant disease are discussed in this evidence-based review.
How to cite this article:
Andharia M, Rai J, Shah M, Sonavane P. An evidence-based review on host modulatory agents in treatment of peri-implant disease.Adv Hum Biol 2023;13:10-16
|
How to cite this URL:
Andharia M, Rai J, Shah M, Sonavane P. An evidence-based review on host modulatory agents in treatment of peri-implant disease. Adv Hum Biol [serial online] 2023 [cited 2023 Mar 31 ];13:10-16
Available from: https://www.aihbonline.com/article.asp?issn=2321-8568;year=2023;volume=13;issue=1;spage=10;epage=16;aulast=Andharia;type=0 |
|
|
|
